Status:
COMPLETED
Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal
Lead Sponsor:
Tokyo University
Collaborating Sponsors:
Asian Development Bank Japan Scholarship Program
Open Society Institute
Conditions:
HIV Infections
Antiretroviral Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Antiretroviral therapy (ART) has been a game changer in the context of HIV-epidemic. From 2005 to 2015, HIV-related deaths have fallen by 45% thanks to ART. However, ART's success heavily depends on H...
Detailed Description
Background Antiretroviral therapy (ART) has been a game changer in the context of HIV-epidemic. From 2005 to 2015, HIV-related deaths have fallen by 45% thanks to ART. In addition, ART has produced a ...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Eligibility criteria
- be 18 years or over;
- own a mobile phone;
- started treatment following test and treat strategy; and
- under the first line ART regimen
- Exclusion criteria HIV-positive individuals will be excluded if they have severe physical and mental illnesses.
Exclusion
Key Trial Info
Start Date :
October 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
468 Patients enrolled
Trial Details
Trial ID
NCT03367130
Start Date
October 14 2017
End Date
June 30 2018
Last Update
September 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seti Zonal Hospital
Dhangadi, State 7., Nepal